Ocugen Files Definitive Proxy Statement for 2025 Shareholder Meeting
Ticker: OCGN · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Ocugen's proxy statement is out for the June 5th meeting - vote on directors & auditors.
AI Summary
Ocugen, Inc. filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting on June 5, 2025. The filing details matters to be voted on by shareholders, including the election of directors and the ratification of its independent registered public accounting firm. The company, previously known as Histogenics Corp, is focused on biological products.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and governance at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual shareholder meeting, not indicating immediate operational or financial risk.
Key Numbers
- DEF 14A — Filing Type (Definitive Proxy Statement)
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- Histogenics Corp (company) — Former company name
- 20250425 (date) — Filing date
- 20250605 (date) — Meeting date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information regarding the matters to be voted on at Ocugen, Inc.'s annual meeting of shareholders.
When is Ocugen, Inc.'s annual meeting scheduled to take place?
Ocugen, Inc.'s annual meeting is scheduled to take place on June 5, 2025.
What is the filing date of this Definitive Proxy Statement?
This Definitive Proxy Statement was filed on April 25, 2025.
What is Ocugen, Inc.'s Standard Industrial Classification code?
Ocugen, Inc.'s Standard Industrial Classification code is 2836, which pertains to Biological Products (No Diagnostic Substances).
Has Ocugen, Inc. undergone a name change previously?
Yes, Ocugen, Inc. was formerly known as Histogenics Corp, with the date of name change being August 10, 2006.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Ocugen, Inc. (OCGN).